were assessed in a collaborative study of two centers comparing 38 girls (I), receiving 0.3 -0.5 mg EE daily, with 44 girls on 0.1 mg EE daily (11). To minimize errors of height prediction (HP) bone ages (BA) were determined according to GREULICH and PYLE by using the mean of four determinations of both centers. Final height (FH) was predict according to the tables of BAYLEY and PINNEAU and was measured at a chronological age (CA) of 19.8t1.2 years (y). Prior to EE administration the following findings-did not differ (I vs 11): CA (12.5 vs 12.4 y), BA (12.4 vs 12.4 y), length (t3.2 vs t 3.2 SOS) and HP (t3.8 vs t3.8 SDS). Evaluation of the differences between SOS of HP and SDS of FH showed no difference with respect to dose, however, an increased BA at the onset was correlated with a smaller reduction (Table I) (Tanner and Whitehouse, 1978). To examine the effects of spinal irradiation (DXT) on spinal growth independent of GH deficiency we analysed the leg length (LL) minus sitting height (SH) SDS and utilised the cranial group as controls. There was an overall statistically significant difference (p< 0.0001) between the median c/s LL-SH SDS (1.98) and the median cranial LL-SH SDS (0.545). Within the c/s group there was a significant correlation with age at treatment (Spearman's p=0.40 : p< 0.02) but no such correlation for the cranial group. After splitting age at treatment into 3 groups (04 5, 5C 10 and lo+ years) there was a significant difference between the LL-SH SDS of the c/s and cranial groups for each of the age groups.
0.1 mg EE daily (11) . To minimize errors of height prediction (HP) bone ages (BA) were determined according to GREULICH and PYLE by using the mean of four determinations of both centers. Final height (FH) was predict according to the tables of BAYLEY and PINNEAU and was measured at a chronological age (CA) of 19.8t1.2 years (y). Prior to EE administration the following findings-did not differ (I vs 11): CA (12.5 vs 12.4 y), BA (12.4 vs 12.4 y), length (t3.2 vs t 3.2 SOS) and HP (t3.8 vs t3.8 SDS) . Evaluation of the differences between SOS of HP and SDS of FH showed no difference with respect to dose, however, an increased BA at the onset was correlated with a smaller reduction (Table I) (Tanner and Whitehouse, 1978) . To examine the effects of spinal irradiation (DXT) on spinal growth independent of GH deficiency we analysed the leg length (LL) minus sitting height (SH) SDS and utilised the cranial group as controls. There was an overall statistically significant difference (p< 0.0001) between the median c/s LL-SH SDS (1.98) and the median cranial LL-SH SDS (0.545). Within the c/s group there was a significant correlation with age at treatment (Spearman's p=0.40 : p< 0.02) but no such correlation for the cranial group. After splitting age at treatment into 3 groups (04 5, 5C 10 and lo+ years) there was a significant difference between the LL-SH SDS of the c/s and cranial groups for each of the age groups.
In conclusion spinal irradiation has a profound effect on spinal growth and the younger the irradiated child, the greater the subsequent skeletal disproportion. Our most conservative figures indicate that the eventual loss in height is 9cms if irradiated at one year, 7cms at five years and 5.5cms attenyears. 
PUBERTAL DEVELOPMENT IN GIRLS WITH CHRONIC RENAL FAILURE (CRF)
The introduction of dialysis therapy and renal transplantation (TP) for treatment of terminal CRF in children has produced a generation of young adults with late sequelae of pre-and transpubertal uremia. Whereas growth retardation has long been recognizid a s a major problem o f these pts the disturbances o f sexual maturation have been neglekted. W e have followed 38 girls a t different stages of CRF u p t o age 15-26 yrs. Breast and pubic hair development and the time elapsed between stage 8 2 t o menarche deviated from the normal range in about half of the pts. Menarche failed t o enter before age 15 in 45% and was associated with advanced bone maturation (mean TW2 bone age 14.0 yrs.). Menses rarely occured o n dialysis but were often restored after TP. Plasma E2 measured i n 31 girls was decreased according t o age, but usually within normal limits when related t o P H stage. However, in 7 girls with advanced CRF studied repeatedly E 2 did not show the expected rise. Plasma L H was increased in 35% and prolactin in 26% of cases. Response of L H to LHRH was often blunted. W e conclude that in CRF the activity of the hypothalamo-pituitary-gonadal axis i s frequently disturbed resulting in hypergonadotropic hypogonadism. AMP (dbcAMP) and cat' had inhihitcy effects on secretion. dhcAMP inhibited secretion by 49+3%. This effect disappeared in the presence of verapamil, the CX-channel hlocker. Ca-ionophore A23187 inhibited secretion by 30t4X. EGTA and verapamil stinulated secretion by 116+11% and T6+l.l%, respectively. The tacalmodulin inhibitor trifluoperazifie eliminated the A23197 effect. It also interfered with the inhibitory effect of dbcAMP. It is concluded that: 1) the secretory mechanism of hPL is a unique process in which both dhcAMP and calcium exert inhihitory action; 2) the two messenqers interrelate: dhcAMP modifies calcium, which requires a calmodulin complex for its effect; 3) by analogy to other secretory mechanisms, the major amount of hPL is secreted by a constitutive mechanism with only small intracellular storage pools; and 4) the concept of the hypothalamicpituitary analoqy applies to a small fraction of hPL secretion. The placenta as fetal tissue is subjected to alterations of gluconeogenesis like the newborn itself. We studied tissue of term placentae incubated in amino acid solution with 14.0 mnol glucose 11 under gasing with either oxigen or nitrogen. As specific inhibitor of gluconeogenesis 2 mM of 2,5-anhydro-0-mannitol (AM) was used, human insulin was administered at a final concentration of 180 pU/ml. The glucose utilization (U(gluc)), L-lactate (P(1ac)) and pyruyqte production (P(pyr)) were calculated after tracing with (U-C)glucose and separation by HPLC technique.-RESULTS:
1. U(g1uc) was 24.8 % (r1.3 S.D.)(n=g) per g tissue in 120 min.
After AM, the glucose consumption was elevated up to 33.3 % (+4.1) (p*O.Ol)(n=6). Insulin did not significantly influence the elevated U(g1uc) in AM conditions.-2. P(1ac) was lowered by AM from 18.2 % (t2.4) to 12.9 % (+2.3)(p< 0.02)(n-6). Insulin abolished this effect (P(1ac) up to 19.8 % (+5.7)).-3. P(pyr) remained una1 tered by AM and insulin.-4. In hjpoxic conditions with inhibited gluconeogenesis, elevation of U(g1uc) from 38.2 %(+2.2) to 44.5 % (t6.7) was observed. Also P(1ac) increased to 39.1-% (+6.6). Thyrotropin (TSH), Noradrenaline (NA), Adrenaline (A) and isoprenaline (ISNA) induced lipolysis in isolated subcutaneous adipocytes was investigated in vitro. Fat cells were obtained from 16 infants aging 2 weeks-2 months and 10 adults during inguinal hernia operations. Glycerol release was measured as an index of lipolysis. NA increased lipolysis by 80% and A by 100% over the basal values in the infant group and in the adult group 300% and 200% respectively. With the addition of the alpha-2-blocking agent Yohimbine the differences between the doseresponse curves of the infants and adults disappeared. The effect of the beta agonist ISNA was almost identical in infants and adults (600% stimulation, ED50 10 -9 M). In the infant group TSH caused a 600% stimulation of lipolysis with ED50 5xlW4IU/ml. The TSH induced lipolysis was inhibted by preincubation of the medium with TSH antibodies but not influenpedbythepresence of propranolol in the medium. In the adult group: TSH had no lipolytic effect below 1 unit/ml. With this concentration the mean increase was 80%. In conclusion, the lipolytic effect of catecholamines was poor during the first two months of age owing to an increased alpha-2-adrenoceptor mediated inhibition. TSH was during infancy a hormone with higher lipolytic capacity than catecholamines, the only hormones with pronounced lipolytic effect in adults. It is possible that TSH is of importance for the rise of lipolysis which is seen immediately after birth.
